Table 1.
Parameters | HC (n=ll') | RA (n=&Z) | PsA (fn=37) | OA (n-6) |
---|---|---|---|---|
Age (Mean ± SD) | 33±10 | 55±13.6 | 51±11.9 | 67±8 |
Gender | ||||
Female | 78% | 68% | 65% | 33% |
Male | 22% | 32% | 38% | 67% |
CRP | 14+14.1 | 8+9.3 | 3.3+3.2 | |
VAS | 52±30 | 49±25 | 50±10 | |
ACPA | ||||
POS | 60% | 0% | 0% | |
NEG | 40% | 100% | 100% | |
RF | ||||
POS | 65% | 0% | 0% | |
NEG | 35% | 100% | 100% | |
Treatments | ||||
No Medication | 27% | 35% | 100% | |
Methotrexate alone |
10% | 19% | 0% | |
MTX in ombination |
19% | 11% | 0% | |
Anti-TNF | 3% | 5% | 0% | |
Biological | 10% | 16% | 0% | |
Others | 31% | 14% | 0% |